EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
09/15/2023
Back to search
Official data from USPTO
A DIVISION OF GENESIS DRUG DISCOVERY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
55
Latest update
09/15/2023
Trademark type
Combined
Nice classes
42
Filing date
01/02/2019
Registration date
02/07/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/07/2023
Last transaction
09/15/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
10/01/2022
First use in commerce
10/01/2022
Drawing code
3
Owner type
16
Owner location
Hamilton, NJ, US
Examiner
GARTNER, JOHN M
Law office
L20
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized term "GENESIS" below the phrase "A DIVISION OF" and above the phrase "DRUG DISCOVERY" with a stylized depiction of a molecule consisting of fourteen spheres representing atoms that are connected by straight bands representing bonds wherein the letter "I" in "GENESIS" is represented by a vertical band connecting two atoms; the color maroon appears in the letter "GENES" and "S" in "GENESIS"; the colors beige and white appear in the fourteen spheres representing atoms; the color black appears in the phrases "A DIVISION OF" and "DRUG DISCOVERY", in the letter "I" in "GENESIS" and in the straight lines representing bonds; the color white appears in the shading of the atoms.
Holders and representatives
Holders
Genesis Biotechnology Group, LLC
Representatives
Christina E. Brule Heslin Rothenberg Farley & Mesiti P.C.
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Research and development in the pharmaceutical and biotechnology fields
Publications
History of USPTO decisions and trademark events.
55 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/15/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/15/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/15/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/07/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
02/07/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
01/04/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
01/03/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
11/07/2022
IUAF
USE AMENDMENT FILED
10/31/2022
EISU
TEAS STATEMENT OF USE RECEIVED
10/31/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/12/2022
EX5G
SOU EXTENSION 5 GRANTED
04/11/2022
EXT5
SOU EXTENSION 5 FILED
04/05/2022
EEXT
SOU TEAS EXTENSION RECEIVED
04/05/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/30/2021
EX4G
SOU EXTENSION 4 GRANTED
10/28/2021
EXT4
SOU EXTENSION 4 FILED
10/28/2021
EEXT
SOU TEAS EXTENSION RECEIVED
10/28/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/30/2021
EX3G
SOU EXTENSION 3 GRANTED
04/29/2021
EXT3
SOU EXTENSION 3 FILED
04/27/2021
EEXT
SOU TEAS EXTENSION RECEIVED
04/27/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/23/2020
EX2G
SOU EXTENSION 2 GRANTED
10/22/2020
EXT2
SOU EXTENSION 2 FILED
10/15/2020
EEXT
SOU TEAS EXTENSION RECEIVED
10/15/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/21/2020
EX1G
SOU EXTENSION 1 GRANTED
04/20/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
04/20/2020
EXT1
SOU EXTENSION 1 FILED
04/14/2020
EEXT
SOU TEAS EXTENSION RECEIVED
04/14/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/13/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/13/2020
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
04/13/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/13/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/13/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
04/13/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
11/05/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/10/2019
PUBO
PUBLISHED FOR OPPOSITION
09/10/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/21/2019
ALIE
ASSIGNED TO LIE
08/05/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/27/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/22/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/22/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/22/2019
GEAN
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
03/21/2019
GEAP
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
03/21/2019
EPEN
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
03/21/2019
CPEA
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
03/21/2019
DOCK
ASSIGNED TO EXAMINER
03/21/2019
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
01/24/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/23/2019
NWAP
NEW APPLICATION ENTERED
01/05/2019
Continuous trademark protection
Get notified about every new filing that threatens A DIVISION OF GENESIS DRUG DISCOVERY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.